Samsung Biologics announced on the 22nd that it won awards in all six evaluation categories at the '2024 CDMO Leadership Awards.' This award marks the 11th consecutive year of winning since 2013, and it is the sixth time winning in all categories.
Kevin Sharp, Head of Global Sales at Samsung Biologics, is delivering his acceptance speech at the '2024 CDMO Leadership Awards' ceremony held in New York, USA. [Photo by Samsung Biologics]
The CDMO Leadership Awards is a global ceremony hosted by Life Science Leader, a U.S. life sciences industry magazine, and Industry Standard Research (ISR), a pharmaceutical and bio industry research organization. It selects award-winning companies worldwide in the contract development and manufacturing organization (CDMO) sector based on six categories: capability, compatibility, expertise, quality, stability, and service.
Kevin Sharp, Head of Global Sales at Samsung Biologics, said at the awards ceremony held in New York, "The trust relationship with our customers is a key growth driver for Samsung Biologics," adding, "We will continue to strengthen our capabilities as a global CDMO to meet customer expectations and solidify our partnerships."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
